{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:52:23Z","timestamp":1790844743434,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":53,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642294228","type":"print"},{"value":"9783642294235","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-29423-5_22","type":"book-chapter","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T05:26:30Z","timestamp":1345699590000},"page":"547-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antiplatelet Therapy in Peripheral Artery Disease"],"prefix":"10.1007","author":[{"given":"Francesco","family":"Violi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,23]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.300.2.197","volume":"300","author":"FG Fowkes","year":"2008","unstructured":"Ankle Brachial Index Collaboration, Fowkes FG, Murray GD et al (2008) Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300:197\u2013208","journal-title":"JAMA"},{"key":"22_CR2","first-page":"56802","volume":"63","author":"U.S. Food and Drug Administration","year":"1998","unstructured":"U.S. Food and Drug Administration (1998) Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products. Fed Regist 63:56802\u201356819","journal-title":"Fed Regist"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71\u201386","journal-title":"BMJ"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.amjmed.2010.03.017","volume":"123","author":"WS Aronow","year":"2010","unstructured":"Aronow WS (2010) Office management of peripheral arterial disease. Am J Med 123:790\u2013792","journal-title":"Am J Med"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1161\/01.CIR.87.5.1563","volume":"87","author":"F Balsano","year":"1993","unstructured":"Balsano F, Violi F (1993) Effect of picotamide on the clinical progression of peripheral vascular disease. A double-blind placebo-controlled study. The ADEP Group. Circulation 87:1563\u20131569","journal-title":"Circulation"},{"key":"22_CR6","first-page":"84","volume":"14","author":"F Balsano","year":"1989","unstructured":"Balsano F, Coccheri S, Libretti A et al (1989) Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial. J Lab Clin Med 14:84\u201391","journal-title":"J Lab Clin Med"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1160\/TH09-09-0635","volume":"103","author":"S Basili","year":"2010","unstructured":"Basili S, Raparelli V, Vestri AR et al (2010) Comparison of efficacy of antiplatelet treatments for patients with claudication: a meta-analysis. Thromb Haemost 103:766\u2013773","journal-title":"Thromb Haemost"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.105.607846","volume":"114","author":"JA Beckman","year":"2006","unstructured":"Beckman JA, Jaff MR, Creager MA (2006) The United States Preventive Services Task Force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation 114:861\u2013866","journal-title":"Circulation"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archinte.163.8.884","volume":"163","author":"JJ Belch","year":"2003","unstructured":"Belch JJ, Topol EJ, Agnelli G et al (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163:884\u2013892","journal-title":"Arch Intern Med"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"a1840","DOI":"10.1136\/bmj.a1840","volume":"337","author":"J Belch","year":"2008","unstructured":"Belch J, MacCuish A, Campbell I et al (2008) The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:a1840","journal-title":"BMJ"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1001\/jama.2009.623","volume":"301","author":"JS Berger","year":"2009","unstructured":"Berger JS, Krantz MJ, Kittelson JM et al (2009) Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 301:1909\u20131919","journal-title":"JAMA"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2010.09.010","volume":"213","author":"JS Berger","year":"2010","unstructured":"Berger JS, Eraso LH, Xie D et al (2010) Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999\u20132004. Atherosclerosis 213:586\u2013591","journal-title":"Atherosclerosis"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF00280943","volume":"39","author":"M Berrettini","year":"1990","unstructured":"Berrettini M, De Cunto M, Parise P et al (1990) \u201cIn vitro\u201d and \u201cex vivo\u201d effects of picotamide, a combined thromboxane A2-synthase inhibitor and-receptor antagonist, on human platelets. Eur J Clin Pharmacol 39:495\u2013500","journal-title":"Eur J Clin Pharmacol"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.295.2.180","volume":"295","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Steg PG, Ohman EM et al (2006) International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295:180\u2013189","journal-title":"JAMA"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","volume":"49","author":"DL Bhatt","year":"2007","unstructured":"Bhatt DL, Flather MD, Hacke W et al (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49:1982\u20131988","journal-title":"J Am Coll Cardiol"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1160\/TH04-09-0586","volume":"93","author":"AD Blann","year":"2005","unstructured":"Blann AD, Tan KT, Tayebjee MH et al (2005) Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty. Thromb Haemost 93:578\u2013583","journal-title":"Thromb Haemost"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329\u20131339","journal-title":"Lancet"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0049-3848(91)90375-7","volume":"62","author":"M Cattaneo","year":"1991","unstructured":"Cattaneo M, Tenconi PM, Lecchi A et al (1991) In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb Res 62:717\u2013724","journal-title":"Thromb Res"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1161\/CIRCULATIONAHA.108.191170","volume":"118","author":"MA Creager","year":"2008","unstructured":"Creager MA, White CJ, Hiatt WR et al (2008) Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary. Circulation 118:2811\u20132825","journal-title":"Circulation"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/01.CIR.71.3.510","volume":"71","author":"MH Criqui","year":"1985","unstructured":"Criqui MH, Fronek A, Barrett-Connor E et al (1985) The prevalence of peripheral arterial disease in a defined population. Circulation 71:510\u2013515","journal-title":"Circulation"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1161\/CIRCULATIONAHA.108.191172","volume":"118","author":"MH Criqui","year":"2008","unstructured":"Criqui MH, Alberts MJ, Fowkes FG et al (2008) Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? Circulation 118:2830\u20132836","journal-title":"Circulation"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","volume":"261","author":"M Catalano","year":"2007","unstructured":"Critical Leg Ischaemia Prevention Study (CLIPS) Group, Catalano M, Born G et al (2007) Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med 261:276\u2013284","journal-title":"J Intern Med"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.CIR.96.1.69","volume":"96","author":"G Dav\u00ec","year":"1997","unstructured":"Dav\u00ec G, Gresele P, Violi F et al (1997) Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 96:69\u201375","journal-title":"Circulation"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/01.ATV.0000168911.78624.b7","volume":"25","author":"AV Doobay","year":"2005","unstructured":"Doobay AV, Anand SS (2005) Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 25:1463\u20131469","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"11B","DOI":"10.1016\/0002-9149(91)90379-Y","volume":"68","author":"GA FitzGerald","year":"1991","unstructured":"FitzGerald GA (1991) Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 68:11B\u201315B","journal-title":"Am J Cardiol"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jama.2010.221","volume":"303","author":"FG Fowkes","year":"2010","unstructured":"Fowkes FG, Price JF, Stewart MCW et al (2010) Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index. JAMA 303:841\u2013848","journal-title":"JAMA"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0140-6736(92)93216-A","volume":"340","author":"SZ Goldhaber","year":"1992","unstructured":"Goldhaber SZ, Manson JE, Stampfer MJ et al (1992) Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians\u2019 Health Study. Lancet 340:143\u2013145","journal-title":"Lancet"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-0038-1646618","volume":"61","author":"P Gresele","year":"1989","unstructured":"Gresele P, Deckmyn H, Arnout J et al (1989) Characterization of N, N\u2032-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor\/thromboxane A2 receptor antagonist in human platelets. Thromb Haemost 61:479\u2013484","journal-title":"Thromb Haemost"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/1358863X07083278","volume":"12","author":"S Haugen","year":"2007","unstructured":"Haugen S, Casserly IP, Regensteiner JG et al (2007) Risk assessment in the patient with established peripheral arterial disease. Vasc Med 12:343\u2013350","journal-title":"Vasc Med"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.108.191171","volume":"118","author":"WR Hiatt","year":"2008","unstructured":"Hiatt WR, Goldstone J, Smith SC Jr et al (2008) Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation 118:2826\u20132829","journal-title":"Circulation"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","volume":"286","author":"AT Hirsch","year":"2001","unstructured":"Hirsch AT, Criqui MH, Treat-Jacobson D et al (2001) Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286:1317\u20131324","journal-title":"JAMA"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"AT Hirsch","year":"2006","unstructured":"Hirsch AT, Haskal ZJ, Hertzer NR et al (2006a) ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113:e463\u2013e654","journal-title":"Circulation"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"AT Hirsch","year":"2006","unstructured":"Hirsch AT, Haskal ZJ, Hertzer NR et al (2006b) ACC\/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 47:1239\u20131312","journal-title":"J Am Coll Cardiol"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2796.1990.tb00164.x","volume":"227","author":"L Janzon","year":"1990","unstructured":"Janzon L, Bergqvist D, Boberg J et al (1990) Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. J Intern Med 227:301\u2013308","journal-title":"J Intern Med"},{"key":"22_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1532-5415.1985.tb02853.x","volume":"33","author":"WB Kannel","year":"1985","unstructured":"Kannel WB, McGee DL (1985) Update on some epidemiologic features of intermittent claudiation: the Framingham Study. J Am Geriatr Soc 33:13\u201318","journal-title":"J Am Geriatr Soc"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-136-12-200206180-00008","volume":"136","author":"MM McDermott","year":"2002","unstructured":"McDermott MM, Greenland P, Liu K et al (2002) The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 136:873\u2013883","journal-title":"Ann Intern Med"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/aje\/kwi167","volume":"162","author":"MM McDermott","year":"2005","unstructured":"McDermott MM, Liu K, Criqui MH et al (2005) Ankle brachial index and subclinical cardiac and carotid disease: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 162:33\u201341","journal-title":"Am J Epidemiol"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/01.ATV.18.2.185","volume":"18","author":"WT Meijer","year":"1998","unstructured":"Meijer WT, Hoes AW, Rutgers D et al (1998) Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 18:185\u2013192","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1046\/j.1365-2125.1996.00503.x","volume":"42","author":"M Milani","year":"1996","unstructured":"Milani M, Longoni A, Maderna M (1996) Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study. Br J Clin Pharmacol 42:782\u2013785","journal-title":"Br J Clin Pharmacol"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0014-2999(89)90820-0","volume":"169","author":"PA Modesti","year":"1989","unstructured":"Modesti PA, Colella A, Abbate R et al (1989) Competitive inhibition of platelet thromboxane A2 receptor binding by picotamide. Eur J Pharmacol 169:85\u201393","journal-title":"Eur J Pharmacol"},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1476-5381.1994.tb13033.x","volume":"112","author":"PA Modesti","year":"1994","unstructured":"Modesti PA, Cecioni I, Colella A et al (1994) Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist. Br J Pharmacol 112:81\u201386","journal-title":"Br J Pharmacol"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.ehj.2004.07.013","volume":"25","author":"GG Neri Serneri","year":"2004","unstructured":"Neri Serneri GG, Coccheri S, Marubini E et al (2004) Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study. Eur Heart J 25:1845\u20131852","journal-title":"Eur Heart J"},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA et al (2007a) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45:S5\u2013S67","journal-title":"J Vasc Surg"},{"key":"22_CR44","first-page":"81","volume":"26","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA et al (2007b) Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26:81\u2013157","journal-title":"Int Angiol"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.105.570903","volume":"113","author":"AM O\u2019Hare","year":"2006","unstructured":"O\u2019Hare AM, Katz R, Shlipak MG et al (2006) Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 113:388\u2013393","journal-title":"Circulation"},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","volume":"124","author":"RL Pande","year":"2011","unstructured":"Pande RL, Perlstein TS, Beckman JA et al (2011) Secondary Prevention and Mortality in Peripheral Artery Disease. National Health and Nutrition Examination Study, 1999 to 2004. Circulation 124:17\u201323","journal-title":"Circulation"},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.CIR.0000112642.63927.54","volume":"109","author":"HE Resnick","year":"2004","unstructured":"Resnick HE, Lindsay RS, McDermott MM et al (2004) Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109:733\u2013739","journal-title":"Circulation"},{"key":"22_CR48","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1161\/CIRCULATIONAHA.107.187998","volume":"117","author":"W Rosamond","year":"2008","unstructured":"Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25\u2013e146","journal-title":"Circulation"},{"key":"22_CR49","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1378\/chest.08-0686","volume":"133","author":"M Sobel","year":"2008","unstructured":"Sobel M, Verhaeghe R, American College of Chest Physicians et al (2008) Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:815\u2013843","journal-title":"Chest"},{"key":"22_CR50","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","volume":"297","author":"PG Steg","year":"2007","unstructured":"Steg PG, Bhatt DL, Wilson PW et al (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297:1197\u20131206","journal-title":"JAMA"},{"key":"22_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejim.2008.09.013","volume":"20","author":"CD Stehouwer","year":"2009","unstructured":"Stehouwer CD, Clement D, Davidson C et al (2009) EFIM Vascular Medicine Working Group. Peripheral arterial disease: a growing problem for the internist. Eur J Intern Med 20:132\u2013138","journal-title":"Eur J Intern Med"},{"key":"22_CR52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/BF00542494","volume":"33","author":"F Violi","year":"1988","unstructured":"Violi F, Ghiselli A, Iuliano L et al (1988) Inhibition by picotamide of thromboxane production in vitro and ex vivo. Eur J Clin Pharmacol 33:599\u2013602","journal-title":"Eur J Clin Pharmacol"},{"key":"22_CR53","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1056\/NEJMcp064483","volume":"356","author":"C White","year":"2007","unstructured":"White C (2007) Clinical practice. Intermittent claudication. N Engl J Med 356:1241\u20131250","journal-title":"N Engl J Med"}],"container-title":["Handbook of Experimental Pharmacology","Antiplatelet Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-29423-5_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T10:11:52Z","timestamp":1675764712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-29423-5_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642294228","9783642294235"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-29423-5_22","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"23 July 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}